jueves, 21 de diciembre de 2023

Development of Monoclonal Antibody Products Targeting SARS-CoV-2 for Emergency Use Authorization DECEMBER 2023

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/development-monoclonal-antibody-products-targeting-sars-cov-2-emergency-use-authorization?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario